Posintro

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePosintro
Drug Alias Namesaponin-based nanoparticle adjuvant (Nordic Vaccine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenDenmark
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNordic Vaccine A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A